XML 41 R29.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]  
Schedule of Revenue The following sets forth the revenues by source generated from services provided by the Company:
   2023   2022 
Epigenetic biomarker services  $99   $400 
Epigenetic biomarker royalties   27    83 
Life insurance commissions   19    28 
Total revenues  $145   $511